journal article·2018-11-12Open access

Decoding cold ischaemia time impact on kidney graft: the kinetics of the unfolded protein response pathways

Sylvain Le Pape, Ophélie Pasini-Chabot, Pierre Couturier, Pierre-Olivier Delpech, Romain Volmer, Nathalie Quellard, Rutger Ploeg, Thierry Hauet, Raphaël Thuillier

Abstract

The relationship between cold ischaemia time (CIT) and adverse outcome is now acknowledged. However, the underlying mechanisms remain to be defined, which slows the development of adapted therapeutics and diagnostics. We explored the impact of CIT in both preclinical and in vitro models of preservation. We determined that the endoplasmic reticulum (ER) and its stress response (unfolded protein response, UPR) were regulated in close association with CIT; the eIF2α-ATF4 pathway was inhibited early (1-8 h) at the detriment of cell survival, while the ATF6 pathway was activated late (12-24 h) and associated with cell death. The IRE1α-XBP1 branch was activated at reperfusion only if CIT extended beyond 8 h, and had a dual role on cell fate - deleterious through IRE1's RNase activity and beneficial through IRE1α other roles. Finally, the pro-apoptotic factor CHOP was a common target of both ATF6 and IRE1α pathways and was associated with elongated CIT and increased cell death. Microarray analysis of human transplanted kidney confirmed that UPR markers were regulated by CIT and that CHOP was associated with adverse outcome. We show that UPR could be a critical pathway explaining the relationship between CIT and graft outcome, highlighting the potential for UPR-based therapeutics and diagnostics to improve transplantation.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Endoplasmic Reticulum Stress and Disease · Adenosine and Purinergic Signaling · Autophagy in Disease and Therapy

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Inserm, U1082 IRTOMIT Poitiers

Faculté de Médecine et de Pharmacie, Université de Poitiers

CHU Poitiers, Service de Biochimie, Pôle BIOSPHARM

CHU Poitiers, Service d’Urologie, Pôle DUNE

University of Cambridge Metabolic Research Laboratories and National Institute for Health Research

CHU de Poitiers, Dept d’Anatomo-pathologie, Pôle BIOSPHARM

Nuffield Department of Surgical Sciences, University of Oxford

Institut national de la recherche agronomique, IBiSA Plateforme ‘MOPICT’, Unité expérimentale Génétique, expérimentations et systèmes innovants, Domaine Expérimental du Magneraud

Funding

Région Poitou Charentes · CHU de Poitiers · University of Poitiers · Inserm

References (54)

Show source-provided references
1. 10.1034/j.1600-6143.2002.20804.x10.1034/j.1600-6143.2002.20804.x ↗
2. 10.1111/j.1600-6143.2004.00332.x10.1111/j.1600-6143.2004.00332.x ↗
3. 10.1111/j.1600-6143.2012.04311.x10.1111/j.1600-6143.2012.04311.x ↗
4. 10.3109/1073119940911742410.3109/10731199409117424 ↗
5. Favreau F, Giraud S, Bon D, et al. Ischemia reperfusion control: the key of kidney graft outcome. Med Sci. 2013;29:183–188.
6. 10.1002/bjs.966210.1002/bjs.9662 ↗
7. 10.1038/nrneph.2012.8310.1038/nrneph.2012.83 ↗
8. 10.1161/CIRCULATIONAHA.107.75686610.1161/CIRCULATIONAHA.107.756866 ↗
9. 10.1038/nrd397610.1038/nrd3976 ↗
10. 10.3109/21691401.2013.80864710.3109/21691401.2013.808647 ↗
11. 10.1038/nrm219910.1038/nrm2199 ↗
12. 10.1126/science.116798310.1126/science.1167983 ↗
13. 10.1016/j.biocel.2007.01.02010.1016/j.biocel.2007.01.020 ↗
14. 10.1038/ki.2014.30410.1038/ki.2014.304 ↗
15. 10.1038/ki.2014.35910.1038/ki.2014.359 ↗
16. 10.1155/2011/53212710.1155/2011/532127 ↗
17. 10.1073/pnas.121761111010.1073/pnas.1217611110 ↗
18. 10.1681/ASN.V11113810.1681/ASN.V111138 ↗
19. 10.1373/clinchem.2008.11279710.1373/clinchem.2008.112797 ↗
20. 10.1038/cddis.2011.2610.1038/cddis.2011.26 ↗
21. 10.1093/nar/30.1.20710.1093/nar/30.1.207 ↗
22. 10.1093/nar/gks119310.1093/nar/gks1193 ↗
23. 10.1093/bioinformatics/btm25410.1093/bioinformatics/btm254 ↗
24. Hintze J. NCSS 2007. NCSS LLC. Kaysville Utah USA. www.ncss.com. 2007.
25. Robbins SL, Kumar V, Cotran RS. Pathologic basis of disease. 8th ed. pp 1–28. Philadelphia (PA): Saunders/Elsevier; 2010. p. 1450.
26. 10.1016/j.celrep.2013.03.02410.1016/j.celrep.2013.03.024 ↗
27. 10.1101/gad.125070410.1101/gad.1250704 ↗
28. 10.1126/science.110190210.1126/science.1101902 ↗
29. 10.1182/blood-2010-08-30309910.1182/blood-2010-08-303099 ↗
30. 10.1097/TP.000000000000050010.1097/TP.0000000000000500 ↗
31. 10.1097/TP.0b013e318195262310.1097/TP.0b013e3181952623 ↗
32. 10.1111/ctr.1202910.1111/ctr.12029 ↗
33. 10.1097/01.tp.0000251781.36117.2710.1097/01.tp.0000251781.36117.27 ↗
34. 10.1161/01.CIR.104.3.25310.1161/01.CIR.104.3.253 ↗
35. 10.1016/j.bbamcr.2012.04.01310.1016/j.bbamcr.2012.04.013 ↗
36. 10.1038/nrd275510.1038/nrd2755 ↗
37. 10.1016/j.molcel.2009.08.02110.1016/j.molcel.2009.08.021 ↗
38. 10.1126/science.122619110.1126/science.1226191 ↗
39. 10.1038/nrm283810.1038/nrm2838 ↗
40. 10.1073/pnas.080963210610.1073/pnas.0809632106 ↗
41. 10.1016/S1097-2765(00)00108-810.1016/S1097-2765(00)00108-8 ↗
42. 10.1016/j.mrfmmm.2004.06.05610.1016/j.mrfmmm.2004.06.056 ↗
43. 10.1074/jbc.M111.23350210.1074/jbc.M111.233502 ↗
44. Karali E, Bellou S, Stellas D, et al. VEGF signals through ATF6 and PERK to promote endothelial cell survival and angiogenesis in the absence of ER stress. Mol Cell. 2011;286(40):35227–35235. [cité 29 avr 2014]; Disponible sur: http://www.sciencedirect.com/science/article/pii/S109727651400255X
45. 10.1073/pnas.090377510610.1073/pnas.0903775106 ↗
46. 10.1083/jcb.20090301410.1083/jcb.200903014 ↗
47. 10.1016/j.cmet.2012.07.00710.1016/j.cmet.2012.07.007 ↗
48. 10.1093/nar/gkr116110.1093/nar/gkr1161 ↗
49. 10.1371/journal.pone.011094410.1371/journal.pone.0110944 ↗
50. 10.1681/ASN.201506070310.1681/ASN.2015060703 ↗
51. 10.1681/ASN.201602021810.1681/ASN.2016020218 ↗
52. 10.1080/21691401.2017.130440610.1080/21691401.2017.1304406 ↗
53. World Transplant Congress. Poster Abstracts. Abstract# C1671. Am J Transplant. 2014;14:S3:347.
54. 10.1091/mbc.10.11.378710.1091/mbc.10.11.3787 ↗